kwic
compared+to
compared+to
right
off
ON
170
1
100
500
strict
ELIZA cgi-bash version rev. 1.91
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -
return
kwic search for compared to out of >500 occurrences
270181 occurrences (No.97 in the rank) during 5 years in the PubMed. [cache]
--- ABSTRACT ---
--- ABSTRACT END ---
[frequency of next (right) word to compared to]
270181 occurrences (No.97 in the rank) during 5 years in the PubMed. [cache]
| 170) Studies investigating late effects among survivors of any primary cancer reported that AYA cancer survivors were at higher risk of SMN, chronic conditions, and all-cause mortality compared to controls. |
| PMID:34638350 DOI:10.3390/cancers13194870 |
| 2021 Cancers |
| * The Burden of Late Effects and Related Risk Factors in Adolescent and Young Adult Cancer Survivors: A Scoping Review. |
| - Risk factors associated with late effects in survivors of adolescent and young adult (AYA) cancer are poorly understood. We conducted a systematic scoping review to identify cohort studies published in English from 2010-2020 that included: (1) cancer survivors who were AYAs (age 15-39 years) at diagnosis and (2) outcomes of subsequent malignant neoplasms (SMNs), chronic conditions, and/or late mortality (>5 years postdiagnosis). There were 652 abstracts identified and, ultimately, 106 unique studies were included, of which 23, 34, and 54 studies related to the risk of SMNs, chronic conditions, and mortality, respectively. Studies investigating late effects among survivors of any primary cancer reported that AYA cancer survivors were at higher risk of SMN, chronic conditions, and all-cause mortality compared to controls. There was an indication that the following factors increased risk: radiation exposure (n = 3) for SMNs; younger attained age (n = 4) and earlier calendar period of diagnosis (n = 3) for chronic conditions; and non-Hispanic Black or Hispanic (n = 5), low socioeconomic status (n = 3), and earlier calendar period of diagnosis (n = 4) for late mortality. More studies including the full AYA age spectrum, treatment data, and results stratified by age, sex, and cancer type are needed to advance knowledge about late effects in AYA cancer survivors. |
[
right
kwic]
(1)95  the |
(14)5 conventional |
(27)2 ER+ |
(40)2 measures |
| (2)19 other |
(15)5 placebo |
(28)2 LONG |
(41)2 patients |
| (3)18 those |
(16)5 that |
(29)2 PLWH |
(42)2 placebo, |
| (4)16 healthy |
(17)4 standard |
(30)2 TM |
(43)2 poor |
| (5)13 a |
(18)4 women |
(31)2 TomTec |
(44)2 swabs |
| (6)13 controls |
(19)3 group |
(32)2 WT |
(45)2 therapy |
| (7)10 control |
(20)3 males |
(33)2 allogeneic |
(46)2 traditional |
| (8)7 baseline |
(21)3 no |
(34)2 any |
(47)2 uninfected |
| (9)7 their |
(22)3 non-obese |
(35)2 children |
(48)2 untreated |
| (10)6 control, |
(23)3 wild-type |
(36)2 expert |
(49)2 usual |
| (11)6 individuals |
(24)2 B-385 |
(37)2 females |
|
| (12)6 normal |
(25)2 CON |
(38)2 field |
|
| (13)5 controls, |
(26)2 CS- |
(39)2 irradiated |
add keyword
--- WordNet output for compared ---